{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:05:09Z","timestamp":1778637909267,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antimalarial chemotherapy, globally reliant on artemisinin-based combination therapies (ACTs), is threatened by the spread of drug resistance in<jats:italic>Plasmodium falciparum<\/jats:italic>parasites. Here we use zinc-finger nucleases to genetically modify the multidrug resistance-1 transporter PfMDR1 at amino acids 86 and 184, and demonstrate that the widely prevalent N86Y mutation augments resistance to the ACT partner drug amodiaquine and the former first-line agent chloroquine. In contrast, N86Y increases parasite susceptibility to the partner drugs lumefantrine and mefloquine, and the active artemisinin metabolite dihydroartemisinin. The PfMDR1 N86 plus Y184F isoform moderately reduces piperaquine potency in strains expressing an Asian\/African variant of the chloroquine resistance transporter PfCRT. Mutations in both digestive vacuole-resident transporters are thought to differentially regulate ACT drug interactions with host haem, a product of parasite-mediated haemoglobin degradation. Global mapping of these mutations illustrates where the different ACTs could be selectively deployed to optimize treatment based on regional differences in PfMDR1 haplotypes.<\/jats:p>","DOI":"10.1038\/ncomms11553","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T10:29:23Z","timestamp":1463567363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":280,"title":["Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies"],"prefix":"10.1038","volume":"7","author":[{"given":"M. Isabel","family":"Veiga","sequence":"first","affiliation":[]},{"given":"Satish K.","family":"Dhingra","sequence":"additional","affiliation":[]},{"given":"Philipp P.","family":"Henrich","sequence":"additional","affiliation":[]},{"given":"Judith","family":"Straimer","sequence":"additional","affiliation":[]},{"given":"Nina","family":"Gn\u00e4dig","sequence":"additional","affiliation":[]},{"given":"Anne-Catrin","family":"Uhlemann","sequence":"additional","affiliation":[]},{"given":"Rowena E.","family":"Martin","sequence":"additional","affiliation":[]},{"given":"Adele M.","family":"Lehane","sequence":"additional","affiliation":[]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"BFncomms11553_CR1","unstructured":"WHO. Malaria World Report. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2015\/en (2015)."},{"key":"BFncomms11553_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cb300454t","volume":"8","author":"JM Combrinck","year":"2013","unstructured":"Combrinck, J. M. et al. Insights into the role of heme in the mechanism of action of antimalarials. ACS Chem. Biol. 8, 133\u2013137 (2013).","journal-title":"ACS Chem. Biol."},{"key":"BFncomms11553_CR3","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/sj.emboj.7601203","volume":"25","author":"P Rohrbach","year":"2006","unstructured":"Rohrbach, P. et al. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 25, 3000\u20133011 (2006).","journal-title":"EMBO J."},{"key":"BFncomms11553_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.mib.2013.07.005","volume":"16","author":"N Klonis","year":"2013","unstructured":"Klonis, N., Creek, D. J. & Tilley, L. Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins. Curr. Opin. Microbiol. 16, 722\u2013727 (2013).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFncomms11553_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411\u2013423 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11553_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50\u201355 (2014).","journal-title":"Nature"},{"key":"BFncomms11553_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer, J. et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347, 428\u2013431 (2015).","journal-title":"Science"},{"key":"BFncomms11553_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet. 47, 226\u2013234 (2015).","journal-title":"Nat. Genet."},{"key":"BFncomms11553_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJMc1403007","volume":"371","author":"DL Saunders","year":"2014","unstructured":"Saunders, D. L. et al. Dihydroartemisinin-piperaquine failure in Cambodia. N. Engl. J. Med. 371, 484\u2013485 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11553_CR10","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang, R. et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob. Agents Chemother. 59, 4719\u20134726 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga, C. et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u2013365 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"BFncomms11553_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TN Wells","year":"2015","unstructured":"Wells, T. N., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nat. Rev. Drug Discov. 14, 424\u2013442 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms11553_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jis747","volume":"207","author":"M Malmberg","year":"2013","unstructured":"Malmberg, M. et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J. Infect. Dis. 207, 842\u2013847 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11553_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiu141","volume":"210","author":"MD Conrad","year":"2014","unstructured":"Conrad, M. D. et al. Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. J. Infect. Dis. 210, 344\u2013353 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11553_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan, M. et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am. J. Trop. Med. Hyg. 91, 833\u2013843 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFncomms11553_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrmicro3450","volume":"13","author":"TF de Koning-Ward","year":"2015","unstructured":"de Koning-Ward, T. F., Gilson, P. R. & Crabb, B. S. Advances in molecular genetic systems in malaria. Nat. Rev. Microbiol. 13, 373\u2013387 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms11553_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","volume":"27","author":"SG Valderramos","year":"2006","unstructured":"Valderramos, S. G. & Fidock, D. A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27, 594\u2013601 (2006).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFncomms11553_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00436-006-0246-4","volume":"100","author":"CT Happi","year":"2006","unstructured":"Happi, C. T. et al. Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria. Parasitol. Res. 100, 141\u2013148 (2006).","journal-title":"Parasitol. Res."},{"key":"BFncomms11553_CR19","doi-asserted-by":"publisher","first-page":"18883","DOI":"10.1073\/pnas.0911317106","volume":"106","author":"JM Sa","year":"2009","unstructured":"Sa, J. M. et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl Acad. Sci. USA 106, 18883\u201318889 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11553_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock, D. A. et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6, 861\u2013871 (2000).","journal-title":"Mol. Cell"},{"key":"BFncomms11553_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molbiopara.2007.09.008","volume":"157","author":"JK Lekostaj","year":"2008","unstructured":"Lekostaj, J. K., Amoah, L. E. & Roepe, P. D. A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform. Mol. Biochem. Parasitol. 157, 107\u2013111 (2008).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFncomms11553_CR22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2958.2008.06413.x","volume":"70","author":"CP Sanchez","year":"2008","unstructured":"Sanchez, C. P., Rotmann, A., Stein, W. D. & Lanzer, M. Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol. Microbiol. 70, 786\u2013798 (2008).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","volume":"403","author":"MB Reed","year":"2000","unstructured":"Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K. & Cowman, A. F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403, 906\u2013909 (2000).","journal-title":"Nature"},{"key":"BFncomms11553_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","volume":"57","author":"AB Sidhu","year":"2005","unstructured":"Sidhu, A. B., Valderramos, S. G. & Fidock, D. A. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57, 913\u2013926 (2005).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/MMBR.00059-13","volume":"78","author":"AH Lee","year":"2014","unstructured":"Lee, A. H., Symington, L. S. & Fidock, D. A. DNA repair mechanisms and their biological roles in the malaria parasite Plasmodium falciparum. Microbiol. Mol. Biol. Rev. 78, 469\u2013486 (2014).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFncomms11553_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nmeth.2143","volume":"9","author":"J Straimer","year":"2012","unstructured":"Straimer, J. et al. Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases. Nat. Methods 9, 993\u2013998 (2012).","journal-title":"Nat. Methods"},{"key":"BFncomms11553_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12782","volume":"504","author":"CW McNamara","year":"2013","unstructured":"McNamara, C. W. et al. Targeting Plasmodium PI(4)K to eliminate malaria. Nature 504, 248\u2013253 (2013).","journal-title":"Nature"},{"key":"BFncomms11553_CR28","doi-asserted-by":"publisher","first-page":"11672","DOI":"10.1073\/pnas.1507142112","volume":"112","author":"S Pelleau","year":"2015","unstructured":"Pelleau, S. et al. Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc. Natl Acad. Sci. USA 112, 11672\u201311677 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11553_CR29","doi-asserted-by":"crossref","unstructured":"MalariaGEN Plasmodium falciparum Community Project. Genomic epidemiology of artemisinin resistant malaria. Elife 5, pii: e08714 (2016).","DOI":"10.7554\/eLife.08714"},{"key":"BFncomms11553_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/mmi.12349","volume":"89","author":"PJ Rosenthal","year":"2013","unstructured":"Rosenthal, P. J. The interplay between drug resistance and fitness in malaria parasites. Mol. Microbiol. 89, 1025\u20131038 (2013).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nyas.12766","volume":"1342","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison, S. & Laufer, M. K. Antimalarial drug resistance in Africa: key lessons for the future. Ann. N. Y. Acad. Sci. 1342, 62\u201367 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFncomms11553_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","volume":"4","author":"K Hayton","year":"2008","unstructured":"Hayton, K. et al. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4, 40\u201351 (2008).","journal-title":"Cell Host Microbe"},{"key":"BFncomms11553_CR33","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1038\/ncomms5029","volume":"5","author":"D Birth","year":"2014","unstructured":"Birth, D., Kao, W. C. & Hunte, C. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action. Nat. Commun. 5, 4029 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms11553_CR34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect. Dis. 13, 1043\u20131049 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"BFncomms11553_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price, R. N. et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438\u2013447 (2004).","journal-title":"Lancet"},{"key":"BFncomms11553_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ijpara.2008.03.004","volume":"38","author":"EH Ekland","year":"2008","unstructured":"Ekland, E. H. & Fidock, D. A. In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. Int. J. Parasitol. 38, 743\u2013747 (2008).","journal-title":"Int. J. Parasitol."},{"key":"BFncomms11553_CR37","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","volume":"43","author":"RN Price","year":"1999","unstructured":"Price, R. N. et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43, 2943\u20132949 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR38","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1128\/AAC.00032-10","volume":"54","author":"M Imwong","year":"2010","unstructured":"Imwong, M. et al. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 54, 2886\u20132892 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR39","doi-asserted-by":"publisher","first-page":"e20212","DOI":"10.1371\/journal.pone.0020212","volume":"6","author":"MI Veiga","year":"2011","unstructured":"Veiga, M. I. et al. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PLoS ONE 6, e20212 (2011).","journal-title":"PLoS ONE"},{"key":"BFncomms11553_CR40","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1128\/AAC.47.8.2418-2423.2003","volume":"47","author":"AL Pickard","year":"2003","unstructured":"Pickard, A. L. et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47, 2418\u20132423 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR41","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.05141-14","volume":"59","author":"P Tumwebaze","year":"2015","unstructured":"Tumwebaze, P. et al. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob. Agents Chemother. 59, 3018\u20133030 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR42","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1086\/427997","volume":"191","author":"C Sisowath","year":"2005","unstructured":"Sisowath, C. et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191, 1014\u20131017 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11553_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-micro-091313-103537","volume":"68","author":"PA Sigala","year":"2014","unstructured":"Sigala, P. A. & Goldberg, D. E. The peculiarities and paradoxes of Plasmodium heme metabolism. Annu. Rev. Microbiol. 68, 259\u2013278 (2014).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFncomms11553_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.1365-2958.2003.03627.x","volume":"49","author":"J Mu","year":"2003","unstructured":"Mu, J. et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49, 977\u2013989 (2003).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren, G. et al. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 6, 309\u2013314 (2006).","journal-title":"Infect. Genet. Evol."},{"key":"BFncomms11553_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(07)60236-0","volume":"369","author":"I Zongo","year":"2007","unstructured":"Zongo, I. et al. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369, 491\u2013498 (2007).","journal-title":"Lancet"},{"key":"BFncomms11553_CR47","doi-asserted-by":"publisher","first-page":"E1759","DOI":"10.1073\/pnas.1322965111","volume":"111","author":"RL Summers","year":"2014","unstructured":"Summers, R. L. et al. Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter. Proc. Natl Acad. Sci. USA 111, E1759\u2013E1767 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11553_CR48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1365-2958.2004.04035.x","volume":"52","author":"MT Ferdig","year":"2004","unstructured":"Ferdig, M. T. et al. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52, 985\u2013997 (2004).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR49","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1128\/AAC.03494-14","volume":"58","author":"N Wurtz","year":"2014","unstructured":"Wurtz, N. et al. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Antimicrob. Agents Chemother. 58, 7032\u20137040 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"AB Sidhu","year":"2002","unstructured":"Sidhu, A. B., Verdier-Pinard, D. & Fidock, D. A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298, 210\u2013213 (2002).","journal-title":"Science"},{"key":"BFncomms11553_CR51","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1365-2958.2011.07855.x","volume":"82","author":"CP Sanchez","year":"2011","unstructured":"Sanchez, C. P., Mayer, S., Nurhasanah, A., Stein, W. D. & Lanzer, M. Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum. Mol. Microbiol. 82, 865\u2013878 (2011).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molbiopara.2010.05.012","volume":"173","author":"P Pleeter","year":"2010","unstructured":"Pleeter, P., Lekostaj, J. K. & Roepe, P. D. Purified Plasmodium falciparum multi-drug resistance protein (PfMDR1) binds a high affinity chloroquine analogue. Mol. Biochem. Parasitol. 173, 158\u2013161 (2010).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFncomms11553_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1021\/bi101638n","volume":"50","author":"PD Roepe","year":"2011","unstructured":"Roepe, P. D. PfCRT-mediated drug transport in malarial parasites. Biochemistry 50, 163\u2013171 (2011).","journal-title":"Biochemistry"},{"key":"BFncomms11553_CR54","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00018-011-0906-0","volume":"69","author":"RL Summers","year":"2012","unstructured":"Summers, R. L., Nash, M. N. & Martin, R. E. Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics. Cell. Mol. Life Sci. 69, 1967\u20131995 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFncomms11553_CR55","doi-asserted-by":"publisher","first-page":"e23875","DOI":"10.1371\/journal.pone.0023875","volume":"6","author":"PE Ferreira","year":"2011","unstructured":"Ferreira, P. E. et al. PfMDR1: mechanisms of transport modulation by functional polymorphisms. PLoS ONE 6, e23875 (2011).","journal-title":"PLoS ONE"},{"key":"BFncomms11553_CR56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"AB Sidhu","year":"2006","unstructured":"Sidhu, A. B. et al. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528\u2013535 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11553_CR57","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","volume":"213","author":"A Yeka","year":"2016","unstructured":"Yeka, A. et al. Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial. J. Infect. Dis. 213, 1134\u20131142 (2016).","journal-title":"J. Infect. Dis."},{"key":"BFncomms11553_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/mmi.13035","volume":"97","author":"I Petersen","year":"2015","unstructured":"Petersen, I. et al. Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter. Mol. Microbiol. 97, 381\u2013395 (2015).","journal-title":"Mol. Microbiol."},{"key":"BFncomms11553_CR59","doi-asserted-by":"publisher","first-page":"e4551","DOI":"10.1371\/journal.pone.0004551","volume":"4","author":"VI Carrara","year":"2009","unstructured":"Carrara, V. I. et al. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS ONE 4, e4551 (2009).","journal-title":"PLoS ONE"},{"key":"BFncomms11553_CR60","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2214-109X(13)70176-1","volume":"2","author":"U Haque","year":"2014","unstructured":"Haque, U. et al. Malaria burden and control in Bangladesh and prospects for elimination: an epidemiological and economic assessment. Lancet Glob. Health 2, e98\u2013e105 (2014).","journal-title":"Lancet Glob. Health"},{"key":"BFncomms11553_CR61","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/QCO.0b013e32834cd3ed","volume":"24","author":"C O'Brien","year":"2011","unstructured":"O'Brien, C., Henrich, P. P., Passi, N. & Fidock, D. A. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr. Opin. Infect. Dis. 24, 570\u2013577 (2011).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"BFncomms11553_CR62","doi-asserted-by":"crossref","unstructured":"Ecker, A., Lehane, A. M. & Fidock, D. A. Molecular markers of Plasmodium resistance to antimalarials. In: Treatment and prevention of malaria - antimalarial drug chemistry, action and use eds Staines H. M., Krishna S. Springer (2012).","DOI":"10.1007\/978-3-0346-0480-2_13"},{"key":"BFncomms11553_CR63","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1073\/pnas.1110574108","volume":"108","author":"R Xi","year":"2011","unstructured":"Xi, R. et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc. Natl Acad. Sci. USA 108, E1128\u2013E1136 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11553_CR64","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1096\/fj.11-187401","volume":"25","author":"EH Ekland","year":"2011","unstructured":"Ekland, E. H., Schneider, J. & Fidock, D. A. Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches. FASEB J. 25, 3583\u20133593 (2011).","journal-title":"FASEB J."},{"key":"BFncomms11553_CR65","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1128\/AAC.01167-10","volume":"55","author":"AM Lehane","year":"2011","unstructured":"Lehane, A. M., van Schalkwyk, D. A., Valderramos, S. G., Fidock, D. A. & Kirk, K. Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT. Antimicrob. Agents Chemother. 55, 2310\u20132318 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms11553_CR66","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood-2005-11-026963","volume":"109","author":"RE Martin","year":"2007","unstructured":"Martin, R. E. & Kirk, K. Transport of the essential nutrient isoleucine in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Blood 109, 2217\u20132224 (2007).","journal-title":"Blood"},{"key":"BFncomms11553_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","volume":"28","author":"A Ecker","year":"2012","unstructured":"Ecker, A., Lehane, A. M., Clain, J. & Fidock, D. A. PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 28, 504\u2013514 (2012).","journal-title":"Trends Parasitol."},{"key":"BFncomms11553_CR68","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.1175667","volume":"325","author":"RE Martin","year":"2009","unstructured":"Martin, R. E. et al. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 325, 1680\u20131682 (2009).","journal-title":"Science"},{"key":"BFncomms11553_CR69","doi-asserted-by":"publisher","first-page":"36336","DOI":"10.1074\/jbc.M114.614206","volume":"289","author":"S Bellanca","year":"2014","unstructured":"Bellanca, S. et al. Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites. J. Biol. Chem. 289, 36336\u201336351 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11553_CR70","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1021\/acs.biochem.5b00412","volume":"54","author":"PS Callaghan","year":"2015","unstructured":"Callaghan, P. S., Hassett, M. R. & Roepe, P. D. Functional comparison of 45 naturally occurring isoforms of the Plasmodium falciparum chloroquine resistance transporter (PfCRT). Biochemistry 54, 5083\u20135094 (2015).","journal-title":"Biochemistry"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms11553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11553","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T12:34:11Z","timestamp":1718541251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms11553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFncomms11553"],"URL":"https:\/\/doi.org\/10.1038\/ncomms11553","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]},"assertion":[{"value":"20 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11553"}}